公司资料

Dare Bioscience, Inc. 股价、新闻与催化剂

股票代码:
DARE
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

0.85 USD (-0.27%)

收盘价

最后更新: 2026年10月1日

32.1M USD

市值

股价为何变动

截至 2026年10月1日,DARE 下跌 0.27%,收于 $0.8510。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

Dare Bioscience is a women’s health biotechnology company focused on contraceptive and reproductive-health innovation. Its story centers on developing products that address gaps in women’s health and family planning.

所在地与行业分类

Dare is headquartered in the United States and listed on NASDAQ. It sits in specialty women’s health biotechnology.

商业模式特征

The company depends on clinical progress, commercial strategy, and the ability to keep a focused women’s-health pipeline funded. Investors watch product development and market access.

生物医药行业定位

Dare occupies a niche women’s-health position within biotech. It is more focused on reproductive-health innovation than on broad therapeutic diversification.

未来催化剂

  • Daré’s catalysts are hormonal-contraception and women’s-health programs, plus any commercial step that clarifies the company’s path. The market will care about execution more than concept.

近期新闻

新闻标题由机器翻译,详情为英文原文。

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。